NCT06129942 is a NA clinical trial of Bright light box in Parkinson Disease, sponsored by Second Affiliated Hospital of Soochow University.

Who is sponsoring NCT06129942?

NCT06129942 is sponsored by Second Affiliated Hospital of Soochow University.

What drugs are being tested in NCT06129942?

Interventions in NCT06129942: Bright light box, Dim Light box.

What condition does NCT06129942 study?

NCT06129942 studies Parkinson Disease, Sleep Disorder, Circadian Rhythm Disorders.

Is NCT06129942 still recruiting?

NCT06129942 is currently recruiting now. Last updated 12 February 2025.

Last reviewed 2025-02-12 · How we verify

NCT06129942

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Light Therapy in Parkinson's Disease

Recruiting now NA Last updated 12 February 2025

What this trial tests

NA trial testing Bright light box in Parkinson Disease in 50 participants. Currently enrolling.

Timeline

1 September 2021

Primary endpoint
16 May 2026

16 May 2026

Quick facts

Lead sponsor	Second Affiliated Hospital of Soochow University
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	double
Primary purpose	treatment
Enrollment	50
Start date	1 September 2021
Primary completion	16 May 2026
Estimated completion	16 May 2026
Sites	1 location across China

Drugs / interventions tested

Bright light box
Dim Light box

Conditions studied

Parkinson Disease — all drugs for Parkinson Disease →
Sleep Disorder — all drugs for Sleep Disorder →
Circadian Rhythm Disorders — all drugs for Circadian Rhythm Disorders →

Sponsor

Second Affiliated Hospital of Soochow University

Who can join

Adults 50 to 80, any sex, with Parkinson Disease or Sleep Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this randomized controlled trial (RCT) is to clarify the effect of bright light therapy on motor symptoms and sleep disorders in patients with Parkinson's disease.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Bright light therapy in Parkinson's disease: a pilot study on visual pathway improvements.
Xie WY, Lou H, Liu JY, Yin JY, et al · · 2025 · PMID 40355852 · DOI 10.1186/s12888-025-06915-z

Verify or expand the search:

Other recruiting trials for Parkinson Disease

Currently open trials in the same condition.

NCT07399496 — Accelerated TMS for Apathy in PD · NA · recruiting
NCT07371338 — Phase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of IPS101A in Parkinson's Disease Patients · Phase 1 · recruiting
NCT07442370 — The Effect of Functional Rotational Exercises on Fall Risk and Mobility in Parkinson's Disease Patients · NA · recruiting
NCT06848205 — Percept Transitions in FOG and PD · NA · recruiting
NCT07432958 — A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (P · Phase 2 · recruiting

Other Second Affiliated Hospital of Soochow University trials

Trials by the same sponsor.

NCT07327411 — Cetuximab β Combined With PRaG Regimen in the Treatment of EGFR-positive Advanced Refractory Solid Tumors · Phase 2 · not yet recruiting
NCT07241897 — DPP4 Inhibitor Intervention on Post-stroke Cognitive Impairment in Ischemic Stroke Patients With Type 2 Diabetes · Phase 3 · not yet recruiting
NCT07267234 — PRaG-1 Plus PRaG Therapy in Advanced Solid Tumors: A Prospective Clinical Trial (PRaG 10.0) · Phase 2 · not yet recruiting
NCT07095790 — Tirofiban With Sequential Dual Antiplatelet Therapy in Mild Stroke · Phase 4 · recruiting
NCT07002502 — Immune Modulation With PRaG-1 Treatment · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06129942 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Second Affiliated Hospital of Soochow University
Last refreshed: 12 February 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06129942.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing